Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Address
2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE, CA 94005
Founded
2018
Number of Employees
155
Website
http://www.dayonebio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)